Your browser doesn't support javascript.
loading
FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.
Verger, Antoine; Yakushev, Igor; Albert, Nathalie L; van Berckel, Bart; Brendel, Matthias; Cecchin, Diego; Fernandez, Pablo Aguiar; Fraioli, Francesco; Guedj, Eric; Morbelli, Silvia; Tolboom, Nelleke; Traub-Weidinger, Tatjana; Van Weehaeghe, Donatienne; Barthel, Henryk.
Afiliación
  • Verger A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU; IADI, INSERM U1254, Nancy, France.
  • Yakushev I; Department of Nuclear Medicine, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. igor.yakushev@tum.de.
  • Albert NL; Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.
  • van Berckel B; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Brendel M; Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.
  • Cecchin D; Nuclear Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy.
  • Fernandez PA; Department of Radiology, Faculty of Medicine and Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, Galicia, Spain.
  • Fraioli F; Institute of Nuclear Medicine, University College London (UCL), London, UK.
  • Guedj E; APHM, CNRS, Centrale Marseille, Nuclear Medicine Department, Institut Fresnel, Timone Hospital, CERIMED, Aix Marseille Univ, Marseille, France.
  • Morbelli S; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
  • Tolboom N; Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, the Netherlands.
  • Traub-Weidinger T; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Van Weehaeghe D; Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
  • Barthel H; Department of Nuclear Medicine, Leipzig University, Leipzig, Germany.
Eur J Nucl Med Mol Imaging ; 50(6): 1553-1555, 2023 05.
Article en En | MEDLINE | ID: mdl-36869178
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Neuroimagen Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Neuroimagen Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Francia